Drawing for ADENOBIO

USPTO serial 76595520

ADENOBIO

Reviewed by CopyMark Law Group

Reg. 3238587Status 710
Filing date
Status date
Registration date
May 8, 2007
Examiner
PRICE, WANDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ADENOBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

IRA S. DORMAN

IRA S DORMAN LAW OFFICE OF IRA S DORMAN330 ROBERTS ST STE 200EAST HARTFORD, CT 06108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating cardiovascular diseases, namely, ischemic heart diseases, cardiac insufficiency, hypertension, arrhythmias, thrombosis, atherosclerosis, peripheral arterial disease, restenosis, and shock resuscitation; venous disorders, namely, deep venous thrombosis; cerebral diseases, namely, stroke, neurodegenerative pathologies, Alzheimer's disease, Parkinson's disease, sleep pathologies, depression, anxiousness, psychotic disorders, epilepsy, migraine headaches; inflammatory diseases, namely, osteoarthritis, rheumatoid arthritis, alkylosing spondylitis, tendonitis, acute gout, inflammatory bowel diseases, prostates, dysmenorrhoea, post-traumatic oedema, fever, cancer, colorectal cancer, ovarian cancer, breast carcinoma, leukemia, prostate cancer, neuroblastoma, apoptosis processes, cancer cachexia syndrome; inhibiting tumor cell growth; for use as chemotherapy efficacy enhancers; immune diseases induced by virus, namely, herpes, herpes zoster and Aids; diabetes, cholesterol and lipid disorders; eye disease, retina ischemic, retina degeneration, glaucoma, and dry eye; sexual dysfunction, angiogenesis, inner ear disease, neuropathic pain, pain during anaesthesia, pulmonary diseases, cystic fibrosis, pulmonary hypertension, exocrine gland disease; antiseptic preparations; dietary food supplements; animal feed additive for use as a nutritional supplement; and dressings for wounds, burns and surgical useSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 13, 2013C8..CANCELLED SEC. 8 (6-YR)—
May 8, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 6, 2007DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jan 29, 2007IUCNNOTICE OF ALLOWANCE CANCELLED—
Jan 29, 2007MAILPAPER RECEIVED—
Aug 1, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 9, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 19, 2006NPUBNOTICE OF PUBLICATION—
Mar 20, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 17, 2006ALIEASSIGNED TO LIE—
Mar 11, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 7, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 17, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 17, 2006MAILPAPER RECEIVED—
Feb 17, 2006CNSIINQUIRY AS TO SUSPENSION MAILED—
Feb 16, 2006CNSISUSPENSION INQUIRY WRITTEN—
Aug 1, 2005CNSLLETTER OF SUSPENSION MAILED—
Jul 30, 2005CNSLSUSPENSION LETTER WRITTEN—
Jul 1, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 27, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 27, 2005MAILPAPER RECEIVED—
Jan 6, 2005CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2005DOCKASSIGNED TO EXAMINER—
Jun 17, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance